- Mark
Dingemanse (Middelburg, Zeeland, the Netherlands, 1983) is a
Dutch linguist and an Africanist. He is an ****ociate
professor in
Language and Communication...
- is acknowledged.
Muehlan C,
Vaillant C,
Zenklusen I,
Kraehenbuehl S,
Dingemanse J (November 2020). "Clinical pharmacology, efficacy, and
safety of orexin...
- "Transplantation der Hoden". Arch. Anat. Physiol. Wiss. Med. 16: 42–6.
David K;
Dingemanse E;
Freud J; et al. (1935). "Uber
krystallinisches mannliches Hormon aus...
- 1600-0447.1990.tb05343.x. PMID 2248085. S2CID 46550463.
Amrein R, Güntert TW,
Dingemanse J,
Lorscheid T,
Stabl M, Schmid-Burgk W (1992). "Interactions of moclobemide...
-
Westermann 1927
Watson in
Voeltz & Kilian-Hatz 2001
Iwasaki et al. 2007,
Dingemanse et al. 2015
Voeltz & Kilian-Hatz 2001 Samarin,
William J. (1971). "Survey...
- S2CID 248494625.
Muehlan C,
Vaillant C,
Zenklusen I,
Kraehenbuehl S,
Dingemanse J (November 2020). "Clinical pharmacology, efficacy, and
safety of orexin...
- PMC 7689791. PMID 32666570.
Muehlan C,
Vaillant C,
Zenklusen I,
Kraehenbuehl S,
Dingemanse J (November 2020). "Clinical pharmacology, efficacy, and
safety of orexin...
-
clinical use. It was
developed by a team at Hoffmann-La
Roche in the 1990s.
Dingemanse J, Bury M,
Roncari G, Zell M,
Gieschke R,
Gaillard AW,
Odink J, van Brummelen...
- S2CID 206620990.
Muehlan C,
Vaillant C,
Zenklusen I,
Kraehenbuehl S,
Dingemanse J (November 2020). "Clinical pharmacology, efficacy, and
safety of orexin...
- 1080/14728214.2020.1729121. PMID 32064955.
Gehin M,
Storey RF,
Bernaud C,
Dingemanse J (2023). "Clinical
pharmacology of
selatogrel for self-administration...
